|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
2011-5-16
|
|
pubmed:abstractText |
Statin therapy reduces cardiovascular morbidity and mortality. However, a substantial residual cardiovascular risk can be observed in patients receiving this therapy due to persisting lipid abnormalities as well as to the lack of a systematic global risk-reduction strategy. The objective of the study was to assess the prevalence of dyslipidemia in a cohort of patients living in Switzerland and receiving statin therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1424-3997
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
141
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
w13200
|
|
pubmed:meshHeading |
pubmed-meshheading:21574067-Aged,
pubmed-meshheading:21574067-Cardiovascular Diseases,
pubmed-meshheading:21574067-Cholesterol, HDL,
pubmed-meshheading:21574067-Cholesterol, LDL,
pubmed-meshheading:21574067-Cross-Sectional Studies,
pubmed-meshheading:21574067-Dyslipidemias,
pubmed-meshheading:21574067-Female,
pubmed-meshheading:21574067-Humans,
pubmed-meshheading:21574067-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:21574067-Male,
pubmed-meshheading:21574067-Middle Aged,
pubmed-meshheading:21574067-Prevalence,
pubmed-meshheading:21574067-Risk Factors,
pubmed-meshheading:21574067-Sex Factors,
pubmed-meshheading:21574067-Switzerland,
pubmed-meshheading:21574067-Triglycerides
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Persistent dyslipidemia in statin-treated patients: the focus on comprehensive lipid management survey in Swiss patients.
|
|
pubmed:affiliation |
Cardiovascular Center Cardiology, Rämistrasse 100, 8091 Zürich, Switzerland. isabella.sudano@usz.ch
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
